Dr. Julie E Voss, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 13317 Ne 175th St Ste N, Woodinville, WA 98072 Phone: 425-434-1500 Fax: 425-977-9485 |
News Archive
Hamilton Thorne Ltd., a leading provider of advanced laser systems for the regenerative medicine and stem cell research markets, today announced the launch of its new Stiletto™ laser system. The Stiletto™ laser system has broad applications for research with a variety of cells, allowing the Company to enter new and exciting research markets, including developmental and advanced cell biology.
A single high dose of the hallucinogen psilocybin, the active ingredient in so-called "magic mushrooms," was enough to bring about a measureable personality change lasting at least a year in nearly 60 percent of the 51 participants in a new study, according to the Johns Hopkins researchers who conducted it.
Addiction and mental illness are closely related. According to the 2012 National Survey on Drug Use and Health, nearly 8.4 million American adults have a mental illness as well as an addiction.
Mylan Inc. and Pfizer Inc. today announced that Meridian Medical Technologies, a Pfizer subsidiary, has entered into a settlement agreement with Intelliject and Sanofi-Aventis that will resolve pending patent litigation related to Intelliject's 505(b)(2) new drug application (NDA) for its epinephrine auto-injector known as e-cue, which will be manufactured and marketed by Sanofi-Aventis.
› Verified 8 days ago